-
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07170150 ·
Phase: Phase 3 ·
Ages: 50 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
NCT07094516 ·
Phase: Phase 2 ·
Ages: 50 Years to 85 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
NCT07011745 ·
Phase: Phase 3 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Chandler
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
NCT07011732 ·
Phase: Phase 3 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Scottsdale
-
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
NCT05877196 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 65 Years and older ·
Sex: All (male and female)
· Arizona: Phoenix
-
A Study of AMDX-2011P in Participants With Alzheimer's Disease
NCT06514001 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Arizona: Phoenix
-
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
NCT07602582 ·
Phase: Phase 3 ·
Ages: 55 Years and older ·
Sex: All (male and female)
· Arizona: Phoenix
-
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
NCT07589595 ·
Phase: Phase 2 ·
Ages: 55 Years to 85 Years ·
Sex: All (male and female)
· Arizona: Chandler, Scottsdale
-
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
NCT06057909 ·
Phase: Not specified ·
Ages: 50 Years to 95 Years ·
Sex: All (male and female)
· Arizona: Scottsdale
-
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578 ·
Phase: Phase 3 ·
Ages: 50 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Sun City
-
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
NCT05511363 ·
Phase: Phase 3 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
NCT06126224 ·
Phase: Phase 3 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Chandler, Phoenix
-
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
NCT05462106 ·
Phase: Phase 1, Phase 2 ·
Ages: 35 Years to 85 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
NCT06887192 ·
Phase: Phase 2 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Phoenix, Scottsdale, Tucson
-
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787 ·
Phase: Phase 3 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Chandler, Gilbert, Phoenix, Scottsdale
-
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
NCT06947941 ·
Phase: Phase 3 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Gilbert
-
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229 ·
Phase: Phase 3 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Chandler, Scottsdale
-
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673 ·
Phase: Phase 2, Phase 3 ·
Ages: 55 Years to 95 Years ·
Sex: All (male and female)
· Arizona: Chandler, Scottsdale
-
Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
NCT02022943 ·
Phase: Not specified ·
Ages: 18 Years to 110 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
Early-Stage Partner in Care Living Alone Plus
NCT06962111 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 60 Years and older ·
Sex: All (male and female)
· Arizona: Phoenix
-
Goal Setting to Promote Physical Activity Adherence in Midlife Adults
NCT05980052 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 45 Years to 65 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949 ·
Phase: Phase 3 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Chandler, Gilbert, Phoenix, Scottsdale
-
PROMIS and Mobility Evaluation in Sarcoma Patients
NCT07227961 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Arizona: Phoenix
-
Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients
NCT07303998 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 60 Years and older ·
Sex: All (male and female)
· Arizona: Tucson
-
Repurposing Siponimod for Alzheimer's Disease
NCT06639282 ·
Phase: Phase 2 ·
Ages: 50 Years to 85 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352 ·
Phase: Phase 3 ·
Ages: 50 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Phoenix, Sun City
-
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
NCT06847321 ·
Phase: Phase 2 ·
Ages: 55 Years to 80 Years ·
Sex: All (male and female)
· Arizona: Phoenix, Scottsdale
-
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
NCT06808984 ·
Phase: Phase 2 ·
Ages: 55 Years to 90 Years ·
Sex: All (male and female)
· Arizona: Phoenix, Scottsdale
-
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study
NCT05988385 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 55 Years to 85 Years ·
Sex: All (male and female)
· Arizona: Tucson
-
Time Restricted Eating in Alzheimer's Disease
NCT06429124 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 55 Years to 89 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
Trial-Ready Cohort-Down Syndrome (TRC-DS)
NCT04165109 ·
Phase: Not specified ·
Ages: 25 Years to 55 Years ·
Sex: All (male and female)
· Arizona: Phoenix
-
[18F]PI-2620 Phase 3 Histopathological Study
NCT05641688 ·
Phase: Phase 3 ·
Ages: 50 Years and older ·
Sex: All (male and female)
· Arizona: Phoenix, Sun City